Cargando…

Targeted Depletion of Hyaluronic Acid Mitigates Murine Breast Cancer Growth

SIMPLE SUMMARY: Breast cancer often contains excessive stromal matrix components that serve as a barrier to therapy. One such component is hyaluronic acid (HA), which also plays important roles in tumor progression and spread. In this study, we engineered an attenuated Salmonella typhimurium secreti...

Descripción completa

Detalles Bibliográficos
Autores principales: Zamloot, Vic, Ebelt, Nancy Danielle, Soo, Catherine, Jinka, Shweta, Manuel, Edwin R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562634/
https://www.ncbi.nlm.nih.gov/pubmed/36230537
http://dx.doi.org/10.3390/cancers14194614
_version_ 1784808217588531200
author Zamloot, Vic
Ebelt, Nancy Danielle
Soo, Catherine
Jinka, Shweta
Manuel, Edwin R.
author_facet Zamloot, Vic
Ebelt, Nancy Danielle
Soo, Catherine
Jinka, Shweta
Manuel, Edwin R.
author_sort Zamloot, Vic
collection PubMed
description SIMPLE SUMMARY: Breast cancer often contains excessive stromal matrix components that serve as a barrier to therapy. One such component is hyaluronic acid (HA), which also plays important roles in tumor progression and spread. In this study, we engineered an attenuated Salmonella typhimurium secreting a bacterial hyaluronidase (YS-HAse) and show that it degrades HA within murine breast tumors, resulting in enhanced tumor permeability and growth control. YS-HAse represents a promising new therapeutic approach that could also be used alongside current treatments to improve their delivery and effectiveness. ABSTRACT: Hyaluronic acid (HA) is highly elevated in breast cancers compared to normal breast tissue and is associated with increased tumor aggressiveness and poor prognosis. HA interacts with cell-trafficking CD44 receptors to promote tumor cell migration and proliferation and regulates both pro- and anti-inflammatory cytokine production through tumor-associated macrophages. The highly negative charge of HA enables its uptake of vast amounts of water that greatly increases the tumor interstitial fluidic pressure, which, combined with the presence of other extracellular matrix components such as collagen, results in tumor stroma with abnormal vasculature, hypoxia, and increased drug resistance. Thus, the degradation of HA in breast cancer may attenuate growth and improve permeability to anticancer agents. Previous methods to deplete tumor HA have resulted in significant off-tumor effects due to the systemic use of mammalian hyaluronidases. To overcome this, we developed a hyaluronidase-secreting Salmonella typhimurium (YS-HAse) that specifically and preferentially colonizes tumors to deplete HA. We show that the systemic administration of YS-HAse in immunocompetent murine models of breast cancer enhances tumor perfusion, controls tumor growth, and restructures the tumor immune contexture. These studies highlight the utility of YS-HAse as a novel microbial-based therapeutic that may also be combined with existing therapeutic approaches.
format Online
Article
Text
id pubmed-9562634
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-95626342022-10-15 Targeted Depletion of Hyaluronic Acid Mitigates Murine Breast Cancer Growth Zamloot, Vic Ebelt, Nancy Danielle Soo, Catherine Jinka, Shweta Manuel, Edwin R. Cancers (Basel) Article SIMPLE SUMMARY: Breast cancer often contains excessive stromal matrix components that serve as a barrier to therapy. One such component is hyaluronic acid (HA), which also plays important roles in tumor progression and spread. In this study, we engineered an attenuated Salmonella typhimurium secreting a bacterial hyaluronidase (YS-HAse) and show that it degrades HA within murine breast tumors, resulting in enhanced tumor permeability and growth control. YS-HAse represents a promising new therapeutic approach that could also be used alongside current treatments to improve their delivery and effectiveness. ABSTRACT: Hyaluronic acid (HA) is highly elevated in breast cancers compared to normal breast tissue and is associated with increased tumor aggressiveness and poor prognosis. HA interacts with cell-trafficking CD44 receptors to promote tumor cell migration and proliferation and regulates both pro- and anti-inflammatory cytokine production through tumor-associated macrophages. The highly negative charge of HA enables its uptake of vast amounts of water that greatly increases the tumor interstitial fluidic pressure, which, combined with the presence of other extracellular matrix components such as collagen, results in tumor stroma with abnormal vasculature, hypoxia, and increased drug resistance. Thus, the degradation of HA in breast cancer may attenuate growth and improve permeability to anticancer agents. Previous methods to deplete tumor HA have resulted in significant off-tumor effects due to the systemic use of mammalian hyaluronidases. To overcome this, we developed a hyaluronidase-secreting Salmonella typhimurium (YS-HAse) that specifically and preferentially colonizes tumors to deplete HA. We show that the systemic administration of YS-HAse in immunocompetent murine models of breast cancer enhances tumor perfusion, controls tumor growth, and restructures the tumor immune contexture. These studies highlight the utility of YS-HAse as a novel microbial-based therapeutic that may also be combined with existing therapeutic approaches. MDPI 2022-09-23 /pmc/articles/PMC9562634/ /pubmed/36230537 http://dx.doi.org/10.3390/cancers14194614 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Zamloot, Vic
Ebelt, Nancy Danielle
Soo, Catherine
Jinka, Shweta
Manuel, Edwin R.
Targeted Depletion of Hyaluronic Acid Mitigates Murine Breast Cancer Growth
title Targeted Depletion of Hyaluronic Acid Mitigates Murine Breast Cancer Growth
title_full Targeted Depletion of Hyaluronic Acid Mitigates Murine Breast Cancer Growth
title_fullStr Targeted Depletion of Hyaluronic Acid Mitigates Murine Breast Cancer Growth
title_full_unstemmed Targeted Depletion of Hyaluronic Acid Mitigates Murine Breast Cancer Growth
title_short Targeted Depletion of Hyaluronic Acid Mitigates Murine Breast Cancer Growth
title_sort targeted depletion of hyaluronic acid mitigates murine breast cancer growth
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562634/
https://www.ncbi.nlm.nih.gov/pubmed/36230537
http://dx.doi.org/10.3390/cancers14194614
work_keys_str_mv AT zamlootvic targeteddepletionofhyaluronicacidmitigatesmurinebreastcancergrowth
AT ebeltnancydanielle targeteddepletionofhyaluronicacidmitigatesmurinebreastcancergrowth
AT soocatherine targeteddepletionofhyaluronicacidmitigatesmurinebreastcancergrowth
AT jinkashweta targeteddepletionofhyaluronicacidmitigatesmurinebreastcancergrowth
AT manueledwinr targeteddepletionofhyaluronicacidmitigatesmurinebreastcancergrowth